Skip to content
Search

Latest Stories

Top Stories

Watchdogs want to extend limits on board service by House members

Watchdogs want to extend limits on board service by House members

GOP Rep. Chris Collins of New York at his August 2018 arraignment on insider trading charges.

Spencer Platt/Getty Images

The prohibition on House members serving as directors of outside groups should include nonprofit and private company boards, not only publicly traded enterprises, three prominent watchdog groups say.

The House has barred its members from such corporate boards only since January. The new Democratic majority changed the rules largely in response to the case of Republican Rep. Chris Collins of New York, charged a year ago with fraud, conspiracy and lying to the FBI in an alleged insider stock trading scheme involving Innate Immunotherapeutics, a biotech company where he was a board member. (Collins was re-elected last fall and is set to go on trial in February.)

The rules change resolution also set up a pair of House members to help the Ethics Committee recommend by the end of the year whether members and their aides should also be restricted from holding other outside positions.


Craig Holman of Public Citizen, a progressive consumer and democracy reform advocacy group, told the panel that House members holding board positions at private entities pose a widespread risk of conflicts of interest. He cited unpublished reporting by The New York Times that at least 60 members sit on the boards of private companies, most of which are limited liability corporations.

"I would like to again urge you to go a little further than banning members from sitting on publicly owned corporate boards," he said at a hearing in late July. "The same types of conflicts of interest apply to for-profit corporations. And so, I encourage you to take a look at extending the ban to for-profit corporations across the board."

That recommendation was also endorsed in a written statement from Issue One, a cross-partisan political reform group. (It is incubating, but journalistically independent from, The Fulcrum)

Susan Wild of Pennsylvania, the Democrat on the working group, said she was "very concerned" about members' relationship to LLCs. At a minimum, she said she would propose that all partners in such entities be disclosed on congressional financial disclosures.

Donald Sherman, deputy director at Citizens for Responsibility and Ethics in Washington (CREW), said the potential for conflicts of interest also applies to positions at closely held companies.

CREW, Public Citizen and Issue One also asked the committee to consider restricting members from taking board positions at nonprofit organizations, specifically those that lobby the federal government, receive public funds or engage in "dark money" spending to influence elections.

Delaney Marsco, an ethics attorney at Campaign Legal Center, said the new rule banning positions at publicly traded companies was an "important first step" but urged the House to go further, including a ban on members holding positions at companies with federal contracts.

Other recommendations to the working group included further restricting congressional stock trading or ownership. But the Republican member, Van Taylor of Texas, reminded the witnesses that the panel's charge was limited to studying outside positions.

Read More

The Voting Rights Act Turns 60 — but Its Promise Is Still Under Threat

The Voting Rights Act of 1965, signed by President Lyndon B. Johnson on August 6 of that year, effectively prohibited racial discrimination in voting and required federal oversight to ensure its implementation. But the promise of the now seminal Voting Rights Act is at risk as Americans mark this milestone anniversary.

LOC; The 19th

The Voting Rights Act Turns 60 — but Its Promise Is Still Under Threat

Sixty years ago, a landmark piece of voting rights legislation was signed into law — a policy that has aimed to course-correct America’s wobbled experiment of representative democracy.

The Voting Rights Act of 1965, signed by President Lyndon B. Johnson on August 6 of that year, effectively prohibited racial discrimination in voting and required federal oversight to ensure its implementation.

Keep ReadingShow less
Time to Toughen Up: Democrats Face a Crossroads

Democrats Donkey lifts weights

Time to Toughen Up: Democrats Face a Crossroads

As the 2026 midterms loom, a simmering debate within Democratic circles has reached a boiling point: Should the party abandon the moral high ground and play political hardball?

In recent years, Democrats have leaned heavily on the ethos of civility and hope—famously embodied by Michelle Obama’s 2016 rallying cry, “When they go low, we go high.” But with the GOP embracing increasingly combative rhetoric and tactics, some strategists argue it’s time for Democrats to recalibrate their messaging—and their muscle.

Keep ReadingShow less
Trump’s Drug Price Ultimatum and the Rise of Enemy Politics
shallow focus photography of prescription bottle with capsules

Trump’s Drug Price Ultimatum and the Rise of Enemy Politics

In an era increasingly defined by transactional politics, the rhetoric of ultimatum has become one of President Donald Trump's favorite tools. When he declared to pharmaceutical giants on August 1st, "We will deploy every tool in our arsenal" should they fail to lower drug prices, it echoed a familiar pattern of the use of "demand" to shift from negotiation to confrontation. Trump's all-too-familiar pattern of prescribing with deadlines, threats of tariffs or sanctions, and appeals to fairness or national pride.

In his letter to 17 major drug manufacturers, Trump demanded that drug manufacturers slash prices to match "most favored nation" levels—the lowest rates offered in other developed countries. He emphasized that Americans are "demanding lower drug prices and they need them today." His language, though cloaked in populist concern, carried a veiled threat:

Keep ReadingShow less